Loading…

Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate

For folate-receptor-targeted anticancer therapy, docetaxel (DTX) nanoparticles (NPs) were produced employing polylactide-co-glycolide-polyethylene glycol-folate (PLGA-PEG-FOL) conjugate. The FOL-conjugated di-block copolymer was synthesized by coupling the PLGA-PEG-NH2 di-block copolymer with an act...

Full description

Saved in:
Bibliographic Details
Published in:Journal of drug targeting 2008-01, Vol.16 (5), p.415-423
Main Authors: Esmaeili, Farnaz, Ghahremani, Mohammad Hossein, Ostad, Seyed Nasser, Atyabi, Fatemeh, Seyedabadi, Mohammad, Malekshahi, Mazda Rad, Amini, Mohsen, Dinarvand, Rassoul
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-d804b3440fc785a40ca2e62c282731baec75e87487057fd59d63e75d3b2a15e83
cites cdi_FETCH-LOGICAL-c465t-d804b3440fc785a40ca2e62c282731baec75e87487057fd59d63e75d3b2a15e83
container_end_page 423
container_issue 5
container_start_page 415
container_title Journal of drug targeting
container_volume 16
creator Esmaeili, Farnaz
Ghahremani, Mohammad Hossein
Ostad, Seyed Nasser
Atyabi, Fatemeh
Seyedabadi, Mohammad
Malekshahi, Mazda Rad
Amini, Mohsen
Dinarvand, Rassoul
description For folate-receptor-targeted anticancer therapy, docetaxel (DTX) nanoparticles (NPs) were produced employing polylactide-co-glycolide-polyethylene glycol-folate (PLGA-PEG-FOL) conjugate. The FOL-conjugated di-block copolymer was synthesized by coupling the PLGA-PEG-NH2 di-block copolymer with an activated folic acid. It was expected that FOL moieties were exposed on the micellar surface. The conjugates assisted in the formation of DTX NPs with an average size of 200 nm in diameter through an emulsification/solvent diffusion method. The FOL-targeted NPs showed a greater extent of intracellular uptake in FOL-receptor-positive cancer cells (SKOV3) in comparison with the non-targeted NPs, indicating that the FOL-receptor-mediated endocytosis mechanism could have a role in the cellular uptake of NPs. These results suggested that FOL-targeted DTX NPs could be a potentially useful delivery system for FOL-receptor-positive cancer cells.
doi_str_mv 10.1080/10611860802088630
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_10611860802088630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20787419</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-d804b3440fc785a40ca2e62c282731baec75e87487057fd59d63e75d3b2a15e83</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS1ERf_AB-CCcoGbYWwntldwqap2QVqpPRSJW-TYkzYrbxxsp7DfHre7gBBSe_Kz_HsznnmEvGbwnoGGDwwkY1oWyUFrKeAZOWLAF5QLAc_vtWS0AN8OyXFKawAmJIMX5JDpRi64lkekuwjeZKQRLU45RJpNvMGMrnLohzuM2yr0lQsWs_mJvhrNGCYT82A9pmqKWC4F7rbV1Wp5Sq_Ol7R_qFjZMK7nm6JekoPe-ISv9ucJ-Xpxfn32ma4ul1_OTlfU1rLJ1GmoO1HX0FulG1ODNRwlt1xzJVhn0KoGtaq1gkb1rlk4KVA1TnTcsPIiTsi7Xd0phu8zptxuhmTRezNimFNbJha6rOpJkIMqfdiigGwH2hhSiti3Uxw2Jm5bBu19Au1_CRTPm33xudug--vYr7wAb_eASdb4PprRDukPx6FmWum6cJ923DD2IW7MjxC9a7PZ-hB_m8Rj__j4j_0Wjc-3tqTVrsMcx5LEI1P8Ai8qstY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20787419</pqid></control><display><type>article</type><title>Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Esmaeili, Farnaz ; Ghahremani, Mohammad Hossein ; Ostad, Seyed Nasser ; Atyabi, Fatemeh ; Seyedabadi, Mohammad ; Malekshahi, Mazda Rad ; Amini, Mohsen ; Dinarvand, Rassoul</creator><creatorcontrib>Esmaeili, Farnaz ; Ghahremani, Mohammad Hossein ; Ostad, Seyed Nasser ; Atyabi, Fatemeh ; Seyedabadi, Mohammad ; Malekshahi, Mazda Rad ; Amini, Mohsen ; Dinarvand, Rassoul</creatorcontrib><description>For folate-receptor-targeted anticancer therapy, docetaxel (DTX) nanoparticles (NPs) were produced employing polylactide-co-glycolide-polyethylene glycol-folate (PLGA-PEG-FOL) conjugate. The FOL-conjugated di-block copolymer was synthesized by coupling the PLGA-PEG-NH2 di-block copolymer with an activated folic acid. It was expected that FOL moieties were exposed on the micellar surface. The conjugates assisted in the formation of DTX NPs with an average size of 200 nm in diameter through an emulsification/solvent diffusion method. The FOL-targeted NPs showed a greater extent of intracellular uptake in FOL-receptor-positive cancer cells (SKOV3) in comparison with the non-targeted NPs, indicating that the FOL-receptor-mediated endocytosis mechanism could have a role in the cellular uptake of NPs. These results suggested that FOL-targeted DTX NPs could be a potentially useful delivery system for FOL-receptor-positive cancer cells.</description><identifier>ISSN: 1061-186X</identifier><identifier>EISSN: 1029-2330</identifier><identifier>DOI: 10.1080/10611860802088630</identifier><identifier>PMID: 18569286</identifier><language>eng</language><publisher>Abington: Informa UK Ltd</publisher><subject>Antineoplastic Agents - administration &amp; dosage ; Antineoplastic Agents - pharmacokinetics ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; Carrier Proteins - metabolism ; Cell Line, Tumor ; Cell Survival - drug effects ; Chromatography, High Pressure Liquid ; docetaxel ; Drug Carriers ; Endocytosis - physiology ; Excipients ; Folate ; Folate Receptors, GPI-Anchored ; Folic Acid - chemistry ; General pharmacology ; Humans ; Lactic Acid - chemistry ; Medical sciences ; nanoparticle ; Nanoparticles ; nanotechnology ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; PLGA ; Polyethylene Glycols - chemistry ; Polyglycolic Acid - chemistry ; Receptors, Cell Surface - metabolism ; targeted delivery ; Taxoids - administration &amp; dosage ; Taxoids - pharmacokinetics ; Taxoids - pharmacology</subject><ispartof>Journal of drug targeting, 2008-01, Vol.16 (5), p.415-423</ispartof><rights>2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-d804b3440fc785a40ca2e62c282731baec75e87487057fd59d63e75d3b2a15e83</citedby><cites>FETCH-LOGICAL-c465t-d804b3440fc785a40ca2e62c282731baec75e87487057fd59d63e75d3b2a15e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20418784$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18569286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Esmaeili, Farnaz</creatorcontrib><creatorcontrib>Ghahremani, Mohammad Hossein</creatorcontrib><creatorcontrib>Ostad, Seyed Nasser</creatorcontrib><creatorcontrib>Atyabi, Fatemeh</creatorcontrib><creatorcontrib>Seyedabadi, Mohammad</creatorcontrib><creatorcontrib>Malekshahi, Mazda Rad</creatorcontrib><creatorcontrib>Amini, Mohsen</creatorcontrib><creatorcontrib>Dinarvand, Rassoul</creatorcontrib><title>Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate</title><title>Journal of drug targeting</title><addtitle>J Drug Target</addtitle><description>For folate-receptor-targeted anticancer therapy, docetaxel (DTX) nanoparticles (NPs) were produced employing polylactide-co-glycolide-polyethylene glycol-folate (PLGA-PEG-FOL) conjugate. The FOL-conjugated di-block copolymer was synthesized by coupling the PLGA-PEG-NH2 di-block copolymer with an activated folic acid. It was expected that FOL moieties were exposed on the micellar surface. The conjugates assisted in the formation of DTX NPs with an average size of 200 nm in diameter through an emulsification/solvent diffusion method. The FOL-targeted NPs showed a greater extent of intracellular uptake in FOL-receptor-positive cancer cells (SKOV3) in comparison with the non-targeted NPs, indicating that the FOL-receptor-mediated endocytosis mechanism could have a role in the cellular uptake of NPs. These results suggested that FOL-targeted DTX NPs could be a potentially useful delivery system for FOL-receptor-positive cancer cells.</description><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Carrier Proteins - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival - drug effects</subject><subject>Chromatography, High Pressure Liquid</subject><subject>docetaxel</subject><subject>Drug Carriers</subject><subject>Endocytosis - physiology</subject><subject>Excipients</subject><subject>Folate</subject><subject>Folate Receptors, GPI-Anchored</subject><subject>Folic Acid - chemistry</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Lactic Acid - chemistry</subject><subject>Medical sciences</subject><subject>nanoparticle</subject><subject>Nanoparticles</subject><subject>nanotechnology</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>PLGA</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Polyglycolic Acid - chemistry</subject><subject>Receptors, Cell Surface - metabolism</subject><subject>targeted delivery</subject><subject>Taxoids - administration &amp; dosage</subject><subject>Taxoids - pharmacokinetics</subject><subject>Taxoids - pharmacology</subject><issn>1061-186X</issn><issn>1029-2330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkU9v1DAQxS1ERf_AB-CCcoGbYWwntldwqap2QVqpPRSJW-TYkzYrbxxsp7DfHre7gBBSe_Kz_HsznnmEvGbwnoGGDwwkY1oWyUFrKeAZOWLAF5QLAc_vtWS0AN8OyXFKawAmJIMX5JDpRi64lkekuwjeZKQRLU45RJpNvMGMrnLohzuM2yr0lQsWs_mJvhrNGCYT82A9pmqKWC4F7rbV1Wp5Sq_Ol7R_qFjZMK7nm6JekoPe-ISv9ucJ-Xpxfn32ma4ul1_OTlfU1rLJ1GmoO1HX0FulG1ODNRwlt1xzJVhn0KoGtaq1gkb1rlk4KVA1TnTcsPIiTsi7Xd0phu8zptxuhmTRezNimFNbJha6rOpJkIMqfdiigGwH2hhSiti3Uxw2Jm5bBu19Au1_CRTPm33xudug--vYr7wAb_eASdb4PprRDukPx6FmWum6cJ923DD2IW7MjxC9a7PZ-hB_m8Rj__j4j_0Wjc-3tqTVrsMcx5LEI1P8Ai8qstY</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Esmaeili, Farnaz</creator><creator>Ghahremani, Mohammad Hossein</creator><creator>Ostad, Seyed Nasser</creator><creator>Atyabi, Fatemeh</creator><creator>Seyedabadi, Mohammad</creator><creator>Malekshahi, Mazda Rad</creator><creator>Amini, Mohsen</creator><creator>Dinarvand, Rassoul</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate</title><author>Esmaeili, Farnaz ; Ghahremani, Mohammad Hossein ; Ostad, Seyed Nasser ; Atyabi, Fatemeh ; Seyedabadi, Mohammad ; Malekshahi, Mazda Rad ; Amini, Mohsen ; Dinarvand, Rassoul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-d804b3440fc785a40ca2e62c282731baec75e87487057fd59d63e75d3b2a15e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Carrier Proteins - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival - drug effects</topic><topic>Chromatography, High Pressure Liquid</topic><topic>docetaxel</topic><topic>Drug Carriers</topic><topic>Endocytosis - physiology</topic><topic>Excipients</topic><topic>Folate</topic><topic>Folate Receptors, GPI-Anchored</topic><topic>Folic Acid - chemistry</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Lactic Acid - chemistry</topic><topic>Medical sciences</topic><topic>nanoparticle</topic><topic>Nanoparticles</topic><topic>nanotechnology</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>PLGA</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Polyglycolic Acid - chemistry</topic><topic>Receptors, Cell Surface - metabolism</topic><topic>targeted delivery</topic><topic>Taxoids - administration &amp; dosage</topic><topic>Taxoids - pharmacokinetics</topic><topic>Taxoids - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Esmaeili, Farnaz</creatorcontrib><creatorcontrib>Ghahremani, Mohammad Hossein</creatorcontrib><creatorcontrib>Ostad, Seyed Nasser</creatorcontrib><creatorcontrib>Atyabi, Fatemeh</creatorcontrib><creatorcontrib>Seyedabadi, Mohammad</creatorcontrib><creatorcontrib>Malekshahi, Mazda Rad</creatorcontrib><creatorcontrib>Amini, Mohsen</creatorcontrib><creatorcontrib>Dinarvand, Rassoul</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of drug targeting</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Esmaeili, Farnaz</au><au>Ghahremani, Mohammad Hossein</au><au>Ostad, Seyed Nasser</au><au>Atyabi, Fatemeh</au><au>Seyedabadi, Mohammad</au><au>Malekshahi, Mazda Rad</au><au>Amini, Mohsen</au><au>Dinarvand, Rassoul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate</atitle><jtitle>Journal of drug targeting</jtitle><addtitle>J Drug Target</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>16</volume><issue>5</issue><spage>415</spage><epage>423</epage><pages>415-423</pages><issn>1061-186X</issn><eissn>1029-2330</eissn><abstract>For folate-receptor-targeted anticancer therapy, docetaxel (DTX) nanoparticles (NPs) were produced employing polylactide-co-glycolide-polyethylene glycol-folate (PLGA-PEG-FOL) conjugate. The FOL-conjugated di-block copolymer was synthesized by coupling the PLGA-PEG-NH2 di-block copolymer with an activated folic acid. It was expected that FOL moieties were exposed on the micellar surface. The conjugates assisted in the formation of DTX NPs with an average size of 200 nm in diameter through an emulsification/solvent diffusion method. The FOL-targeted NPs showed a greater extent of intracellular uptake in FOL-receptor-positive cancer cells (SKOV3) in comparison with the non-targeted NPs, indicating that the FOL-receptor-mediated endocytosis mechanism could have a role in the cellular uptake of NPs. These results suggested that FOL-targeted DTX NPs could be a potentially useful delivery system for FOL-receptor-positive cancer cells.</abstract><cop>Abington</cop><pub>Informa UK Ltd</pub><pmid>18569286</pmid><doi>10.1080/10611860802088630</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1061-186X
ispartof Journal of drug targeting, 2008-01, Vol.16 (5), p.415-423
issn 1061-186X
1029-2330
language eng
recordid cdi_crossref_primary_10_1080_10611860802088630
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Antineoplastic Agents - administration & dosage
Antineoplastic Agents - pharmacokinetics
Antineoplastic Agents - pharmacology
Biological and medical sciences
Carrier Proteins - metabolism
Cell Line, Tumor
Cell Survival - drug effects
Chromatography, High Pressure Liquid
docetaxel
Drug Carriers
Endocytosis - physiology
Excipients
Folate
Folate Receptors, GPI-Anchored
Folic Acid - chemistry
General pharmacology
Humans
Lactic Acid - chemistry
Medical sciences
nanoparticle
Nanoparticles
nanotechnology
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
PLGA
Polyethylene Glycols - chemistry
Polyglycolic Acid - chemistry
Receptors, Cell Surface - metabolism
targeted delivery
Taxoids - administration & dosage
Taxoids - pharmacokinetics
Taxoids - pharmacology
title Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A13%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Folate-receptor-targeted%20delivery%20of%20docetaxel%20nanoparticles%20prepared%20by%20PLGA-PEG-folate%20conjugate&rft.jtitle=Journal%20of%20drug%20targeting&rft.au=Esmaeili,%20Farnaz&rft.date=2008-01-01&rft.volume=16&rft.issue=5&rft.spage=415&rft.epage=423&rft.pages=415-423&rft.issn=1061-186X&rft.eissn=1029-2330&rft_id=info:doi/10.1080/10611860802088630&rft_dat=%3Cproquest_cross%3E20787419%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-d804b3440fc785a40ca2e62c282731baec75e87487057fd59d63e75d3b2a15e83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20787419&rft_id=info:pmid/18569286&rfr_iscdi=true